Harnessing Viral Specific Immunity for Fighting Cancer
Immunotherapy revolutionized cancer treatment, with over 40 products available and annual sales worth over 190 billion USD, providing patients with a variety of novel options
Immunotherapy market size, 2021-2031 (US$B)
However, these treatments suffer from low response rate, only 20% of the patients respond to today’s immunotherapies, on average
Switchable targeting arms and viral moieties, to attack different tumors
Harnessing the power of viral immunity to fight cancer
Specifically targeting cancer cells
Co-Founder & CEO
Co-Founder and R&D
Co-Founder, business development and IP
VP R&D, Immunologist
Protein engineering
Computational Biology
